TY  - JOUR
PY  - 2022//
TI  - Detecting depression and anxiety among adolescents in South Africa: validity of the isiXhosa Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7
JO  - Journal of Adolescent Health
A1  - Marlow, Marguerite
A1  - Skeen, Sarah
A1  - Grieve, Caitlin M.
A1  - Carvajal, Liliana
A1  - Ahs, Jill W.
A1  - Kohrt, Brandon A.
A1  - Requejo, Jennifer
A1  - Stewart, Jaqueline
A1  - Henry, Junita
A1  - Goldstone, Daniel
A1  - Kara, Tashmira
A1  - Tomlinson, Mark
SP  - ePub
EP  - ePub
VL  - ePub
IS  - ePub
N2  - PURPOSE: Screening tools such as the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7) could potentially be used in resource-limited settings to identify adolescents who need mental health support. We examined the criterion validity of the isiXhosa versions of the PHQ-9 and GAD-7 in detecting depression and anxiety among adolescents (10-19 years) in South Africa. <br><br>METHODS: Adolescents were recruited from the general population and from nongovernmental organizations working with adolescents in need of mental health support. The PHQ-9 and GAD-7 were culturally adapted and translated into isiXhosa and administered to 302 adolescents (56.9% female). The Kiddie Schedule for Affective Disorders and Schizophrenia was administered by trained clinicians as the gold standard diagnostic measure for depression and anxiety. <br><br>RESULTS: For the PHQ-9, the area under the curve was 0.88 for the full sample of adolescents (10-19 years old). A score of ≥10 had 91% sensitivity and 76% specificity for detecting adolescents with depression. For the GAD-7, the area under the curve was 0.78, and cutoff scores with an optimal sensitivity-specificity balance were low (≥6). A score of ≥6 had 67% sensitivity and 75% specificity for detecting adolescents with anxiety. <br><br>DISCUSSION: The culturally adapted isiXhosa version of the PHQ-9 can be used as a valid measure for depression in adolescents. Further research on the GAD-7 for use with adolescents is recommended.<p />  <p>Language: en</p>
LA  - en
SN  - 1054-139X
UR  - http://dx.doi.org/10.1016/j.jadohealth.2022.09.013
ID  - ref1
ER  -